341 related articles for article (PubMed ID: 26047946)
41. High-density lipoproteins affect endothelial BMP-signaling by modulating expression of the activin-like kinase receptor 1 and 2.
Yao Y; Shao ES; Jumabay M; Shahbazian A; Ji S; Boström KI
Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2266-74. PubMed ID: 18948634
[TBL] [Abstract][Full Text] [Related]
42. Signal transduction pathway through activin receptors as a therapeutic target of musculoskeletal diseases and cancer.
Tsuchida K; Nakatani M; Uezumi A; Murakami T; Cui X
Endocr J; 2008 Mar; 55(1):11-21. PubMed ID: 17878607
[TBL] [Abstract][Full Text] [Related]
43. ALK2 functions as a BMP type I receptor and induces Indian hedgehog in chondrocytes during skeletal development.
Zhang D; Schwarz EM; Rosier RN; Zuscik MJ; Puzas JE; O'Keefe RJ
J Bone Miner Res; 2003 Sep; 18(9):1593-604. PubMed ID: 12968668
[TBL] [Abstract][Full Text] [Related]
44. Bone Morphogenetic Protein 2 Promotes Human Trophoblast Cell Invasion by Inducing Activin A Production.
Zhao HJ; Chang HM; Zhu H; Klausen C; Li Y; Leung PCK
Endocrinology; 2018 Jul; 159(7):2815-2825. PubMed ID: 29846546
[TBL] [Abstract][Full Text] [Related]
45. Regulation of FSHβ induction in LβT2 cells by BMP2 and an Activin A/BMP2 chimera, AB215.
Jung JW; Ahn C; Shim SY; Gray PC; Kwiatkowski W; Choe S
J Endocrinol; 2014 Oct; 223(1):35-45. PubMed ID: 25100748
[TBL] [Abstract][Full Text] [Related]
46. Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.
Clarke TR; Hoshiya Y; Yi SE; Liu X; Lyons KM; Donahoe PK
Mol Endocrinol; 2001 Jun; 15(6):946-59. PubMed ID: 11376113
[TBL] [Abstract][Full Text] [Related]
47. Activin B Induces Noncanonical SMAD1/5/8 Signaling via BMP Type I Receptors in Hepatocytes: Evidence for a Role in Hepcidin Induction by Inflammation in Male Mice.
Canali S; Core AB; Zumbrennen-Bullough KB; Merkulova M; Wang CY; Schneyer AL; Pietrangelo A; Babitt JL
Endocrinology; 2016 Mar; 157(3):1146-62. PubMed ID: 26735394
[TBL] [Abstract][Full Text] [Related]
48. Novel action of activin and bone morphogenetic protein in regulating aldosterone production by human adrenocortical cells.
Suzuki J; Otsuka F; Inagaki K; Takeda M; Ogura T; Makino H
Endocrinology; 2004 Feb; 145(2):639-49. PubMed ID: 14592955
[TBL] [Abstract][Full Text] [Related]
49. Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins.
Sidis Y; Mukherjee A; Keutmann H; Delbaere A; Sadatsuki M; Schneyer A
Endocrinology; 2006 Jul; 147(7):3586-97. PubMed ID: 16627583
[TBL] [Abstract][Full Text] [Related]
50. Regulation of the activin-inhibin-follistatin system by bone morphogenetic proteins in the zebrafish ovary.
Li CW; Ge W
Biol Reprod; 2013 Sep; 89(3):55. PubMed ID: 23843234
[TBL] [Abstract][Full Text] [Related]
51. Expression of transforming growth factor-beta1, activin A, and their receptors in thyroid follicle cells: negative regulation of thyrocyte growth and function.
Franzén A; Piek E; Westermark B; ten Dijke P; Heldin NE
Endocrinology; 1999 Sep; 140(9):4300-10. PubMed ID: 10465304
[TBL] [Abstract][Full Text] [Related]
52. Involvement of activin signal pathway in cyclic apoptosis of the oviductal isthmic epithelium in cows.
Yamamoto Y; Ito S; Okuda K; Kimura K
Theriogenology; 2020 Sep; 153():143-150. PubMed ID: 32485427
[TBL] [Abstract][Full Text] [Related]
53. Follistatin preferentially antagonizes activin rather than BMP signaling in Drosophila.
Pentek J; Parker L; Wu A; Arora K
Genesis; 2009 Apr; 47(4):261-73. PubMed ID: 19241394
[TBL] [Abstract][Full Text] [Related]
54. Activin A/bone morphogenetic protein (BMP) chimeras exhibit BMP-like activity and antagonize activin and myostatin.
Korupolu RV; Muenster U; Read JD; Vale W; Fischer WH
J Biol Chem; 2008 Feb; 283(7):3782-90. PubMed ID: 18056265
[TBL] [Abstract][Full Text] [Related]
55. Activin type 2 receptor restoration in MSI-H colon cancer suppresses growth and enhances migration with activin.
Jung BH; Beck SE; Cabral J; Chau E; Cabrera BL; Fiorino A; Smith EJ; Bocanegra M; Carethers JM
Gastroenterology; 2007 Feb; 132(2):633-44. PubMed ID: 17258738
[TBL] [Abstract][Full Text] [Related]
56. Adenovirus‑mediated knockdown of activin A receptor type 2A attenuates immune‑induced hepatic fibrosis in mice and inhibits interleukin‑17‑induced activation of primary hepatic stellate cells.
Zhang H; Ju B; Nie Y; Song B; Xu Y; Gao P
Int J Mol Med; 2018 Jul; 42(1):279-289. PubMed ID: 29620144
[TBL] [Abstract][Full Text] [Related]
57. Endometrial receptivity and implantation require uterine BMP signaling through an ACVR2A-SMAD1/SMAD5 axis.
Monsivais D; Nagashima T; Prunskaite-Hyyryläinen R; Nozawa K; Shimada K; Tang S; Hamor C; Agno JE; Chen F; Masand RP; Young SL; Creighton CJ; DeMayo FJ; Ikawa M; Lee SJ; Matzuk MM
Nat Commun; 2021 Jun; 12(1):3386. PubMed ID: 34099644
[TBL] [Abstract][Full Text] [Related]
58. Functional redundancy of type I and type II receptors in the regulation of skeletal muscle growth by myostatin and activin A.
Lee SJ; Lehar A; Liu Y; Ly CH; Pham QM; Michaud M; Rydzik R; Youngstrom DW; Shen MM; Kaartinen V; Germain-Lee EL; Rando TA
Proc Natl Acad Sci U S A; 2020 Dec; 117(49):30907-30917. PubMed ID: 33219121
[TBL] [Abstract][Full Text] [Related]
59. Mutual regulation of follicle-stimulating hormone signaling and bone morphogenetic protein system in human granulosa cells.
Miyoshi T; Otsuka F; Suzuki J; Takeda M; Inagaki K; Kano Y; Otani H; Mimura Y; Ogura T; Makino H
Biol Reprod; 2006 Jun; 74(6):1073-82. PubMed ID: 16436528
[TBL] [Abstract][Full Text] [Related]
60. Intracellular and extracellular control of activin function by novel regulatory molecules.
Tsuchida K; Matsuzaki T; Yamakawa N; Liu Z; Sugino H
Mol Cell Endocrinol; 2001 Jun; 180(1-2):25-31. PubMed ID: 11451568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
